Treatment of acquired haemophilia with recombinant activated FVII: a critical appraisal.


Acquired haemophilia is a rare bleeding disorder usually caused by the spontaneous formation of inhibitory antibodies to coagulation FVIII. The disease occurs most commonly in the elderly, and although acquired haemophilia may be associated with a variety of underlying conditions, up to 50% of reported cases are idiopathic. Treatment options have… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.